Mobidiag Ltd, a Finnish molecular diagnostics company specialized in the development of innovative diagnostics solutions for infectious diseases, today announced the launch of Amplidiag C. difficile+027, a qualitative qPCR-based test performed from DNA extracted from stool in suspected cases of C. difficile infection (CDI).
from The Medical News http://ift.tt/1E9B7Y1
from The Medical News http://ift.tt/1E9B7Y1
No comments:
Post a Comment